Skip to main content

Table 2 Univariate and multivariate Cox analysis of OS in TCGA-BRCA

From: Comprehensive research into prognostic and immune signatures of transcription factor family in breast cancer

Characteristics

Total (N)

Univariate analysis

Multivariate analysis

HR (95% CI)

P value

HR (95% CI)

P value

Age

1082

    

  ≤ 60

601

Reference

   

  > 60

481

2.020 (1.465–2.784)

 < 0.001

3.154 (1.616–6.155)

 < 0.001

T stage

1079

    

 T1

276

Reference

   

 T2

629

1.332 (0.887–1.999)

0.166

1.013 (0.520–1.973)

0.970

 T3&T4

174

1.953 (1.221–3.123)

0.005

1.649 (0.683–3.982)

0.266

N stage

1063

    

 N0

514

Reference

   

 N1

357

1.956 (1.329–2.879)

 < 0.001

1.376 (0.702–2.697)

0.352

 N2

116

2.519 (1.482–4.281)

 < 0.001

2.985 (1.297–6.869)

0.010

 N3

76

4.188 (2.316–7.574)

 < 0.001

6.068 (2.364–15.573)

 < 0.001

M stage

922

    

 M0

902

Reference

   

 M1

20

4.254 (2.468–7.334)

 < 0.001

3.639 (1.152–11.498)

0.028

ER status

1032

    

 Negative

240

Reference

   

 Positive

792

0.712 (0.495–1.023)

0.066

0.469 (0.189–1.164)

0.102

PR status

1029

    

 Negative

342

Reference

   

 Positive

687

0.732 (0.523–1.024)

0.068

1.028 (0.440–2.403)

0.948

HER2 status

715

    

 Negative

558

Reference

   

 Positive

157

1.593 (0.973–2.609)

0.064

0.931 (0.476–1.821)

0.836

Menopause status

931

    

 Pre

229

Reference

   

 Post

702

2.165 (1.302–3.600)

0.003

2.083 (0.863–5.032)

0.103

  1. BRCA Breast cancer; TCGA The Cancer Genome Atlas; OS Over survival; HR Hazard Ratio; 95% CI 95% confidence interval; ER Estrogen receptor; PR Progesterone receptor; HER2 Human epidermal growth factor receptor 2. Bold indicates that the difference is statistically significant